Newborn screening for cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Southern, Kevin W ^a   Mérelle, Marieke M E ^b   Dankert Roelse, Jeannette E ^c   Nagelkerke, Ad ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Infection and Immunology   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

*Neonatal screening; Cystic fibrosis *diagnosis ; Humans; Infant, newborn; Quality of life; Randomized controlled trials as topic; Survival analysis

Indexed keywords

BACTERIAL COLONIZATION; GENOTYPE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG FUNCTION TEST; MALNUTRITION; NEWBORN SCREENING; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; REVIEW; SURVIVAL; THORAX RADIOGRAPHY; CLINICAL TRIAL; COCHRANE LIBRARY; CYSTIC FIBROSIS; FOLLOW UP; NEWBORN MORTALITY; NUTRITIONAL STATUS; OUTCOMES RESEARCH; PROGNOSIS; NEWBORN; RANDOMIZED CONTROLLED TRIAL;

CYSTIC FIBROSIS; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS;

EID: 70249111117     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001402.pub2     Document Type: Review

References (100)

1. Al-Jader LN, Goodchild MC, Ryley HC, Harper PS. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clinical Genetics 1990;38(6):460-465
2. Chatfield S, Owen G, Ryley H, Goodchild M, Weller P. Does early detection lead to an improved prognosis in cystic fibrosis neonates?. Acta Universitatis Carolinae Medica 1990;36(1-4):96-98
3. Chatfield S, Owen G, Ryley HC, Goodchild MC, Weller P. Evaluation of the usefulness of neonatal screening in cystic fibrosis [abstract]. Proceedings of the 14th Annual Meeting of the BAPEN & 27th Annual Meeting of the PRS; Oxford. 1989:A.
4. Chatfield S, Owen G, Ryley HC, Williams J, Goodchild MC, Weller P. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Archives of Disease in Childhood 1991;66(1):29-33.
5. Doull IJ, Ryley HC, Weller P, Goodchild MC. Cystic fibrosis-related deaths in infancy and the effect of newborn screening. Pediatric Pulmonology 2001;31(5):363-366 (Pubitemid 32417254)
6. Doull IJM, Ryley HC, Weller P, Goodchild MC. Death from cystic fibrosis in the first five years of life and the effect of newborn screening [abstract]. 13th International Cystic Fibrosis Congress; 2000 June 4-8; Stockholm, Sweden. 2000; Vol.112.
7. Ryley HC, Deam SM, Williams J, Alfaham M, Weller PH, Goodchild MC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: I. Evaluation of immunoreactive trypsin test. Journal of Clinical Pathology 1988;41(7):726-729 (Pubitemid 18192302)
8. Ryley HC, Desai M, Weller P, Doull I. Clinical status of screened and unscreened CF children at age 10 years [abstract]. Abstracts of the 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna. 2001:P20.
9. Sebire P, Desai M, Millar-Jones L, Lacy D, Ryley HC, Weller PH, et al. Neonatal screening for cystic fibrosis: evidence in favour of screening from clinical scoring systems [abstract]. Proceedings of the 20th European Cystic Fibrosis Conference; 1995 June 18-21; Brussels. 1995.
10. Weller P. Personal communication 2007.
11. Braun AT, Farrell PM, Ferec C, Audrezet MP, Laxova A, Li Z, et al. Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. Journal of Cystic Fibrosis 2006;5(1):33-41.
12. Douglas JA, Rock MJ, Lai HC, Splaingard ML, Becker MA, Zaremba KM, et al. Association of cognitive abilities and head circumference in patients with cystic fibrosis [abstract]. Pediatric Pulmonology 2000; Suppl 20:336.
13. Farrell P, Kosorok M, Rock M, Splaingard M, Laxova A, Zeng L, et al. Pulmonary disease after delayed or with early diagnosis through neonatal screening [abstract]. Journal of Cystic Fibrosis 2002;1(Suppl 1):S16.
14. Farrell PM. Improving the health of patients with cystic fibrosis through newborn screening Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Advances in Pediatrics 2000;47:79-115.
15. Farrell PM, Koscik R, Laxova A, Mischler E, Splaingard M, Laessig R, et al. Neonatal screening for cystic fibrosis: comparison of single test for immunoreactive trypsinogen (IRT) vs IRT/DNA [abstract]. Pediatric Pulmonology 1994; Suppl 10:216-217
16. Farrell PM, Koscik RE, Van Egmond A, Fosorok MR, Laxova A, Feenan L, et al. Early nutritional therapy in cystic fibrosis [abstract]. Pediatric Pulmonology 1995;Suppl 12:90-91
17. Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT, et al. Nutritional benefits of neonatal screening for cystic fibrosis. New England Journal of Medicine 1997;337(14):963-969 (Pubitemid 27425952)
18. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Hoffman G, et al. Assessment of the benefits, risks and costs of cystic fibrosis screening in Wisconsin, USA [abstract]. Proceedings of the Fifth International Conference on Neonatal Screening for Cystic Fibrosis; 1998. 1998:239-253
19. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics 2001;107(1):1-13. (Pubitemid 32055408)
20. Farrell PM, Kosorok MR, Rock MJ, Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Assessments of the benefits, risks, and costs of cystic fibrosis newborn screening in Wisconsin [abstract]. Morbidity and Mortality Weekly Report 1997;46(No.):8-9.
21. Farrell PM, Kosorok MR, Zeng L, Rock MJ, Splaingard M, Laxova A, et al. Assessing pulmonary outcomes associated with early diagnosis through neonatal screening [abstract]. Abstracts of the 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna. 2001: P36.
22. Farrell PM, Lai H, Li Z, Kosorok MR, Laxova A, Green CG, et al. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!. Journal of Pediatrics 2005;147(3 Suppl):S30-6. (Pubitemid 41400256)
23. Farrell PM, Laxova A, Splaingard M, Rock MJ, Zeng L, Kosorok MR, et al. Lung disease severity after diagnosis of cystic fibrosis through neonatal screening [abstract]. Pediatric Pulmonology 2000;Suppl 20: 308.
24. Farrell PM, Li Z, Kosorok M, Laxova A, Green CG, Collins J, et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. American Journal of Respiratory and Critical Care Medicine 2003;168(9):1100-1108
25. Farrell PM, Li Z, Kosorok MR, Laxova A, Collins J. Mucoid pseudomonas aeruginosa infection, antibiotic resistance, and lung disease progression in children with cystic fibrosis [abstract]. Journal of Cystic Fibrosis 2005;4(Suppl):S56.
26. Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, et al. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatric Pulmonology 2003;36(3):230-240
27. Farrell PM, Mischler EH. Newborn screening for cystic fibrosis. Advances in Pediatrics 1992;39:35-70.
28. Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis [abstract]. Pediatrics 1997;100(5):886.
29. Farrell PM, Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Assessment of the benefits and costs of CF neonatal screening in Wisconsin [abstract]. Pediatric Pulmonology 1997;Suppl 14: 192-193
30. Farrell PM, Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Comparison of newborn screening methods and use of the sweat test for diagnosis of cystic fibrosis [abstract]. Morbidity and Mortality Weekly Report 1997;46(No.):11-12
31. Fost N, Farrell PM. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Clinical Research 1989;37(3):495-500. (Pubitemid 19214804)
32. Gregg RG, Simantel A, Farrell PM, Koscik R, Kosorok MR, Laxova A, et al. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. Pediatrics 1997;99(6):819-824 (Pubitemid 27231354)
33. Hassemer DJ, Laessig RH, Hoffman GL, Farrell PM. Laboratory quality control issues related to screening newborns for cystic fibrosis using immunoreactive trypsin. Pediatric Pulmonology 1991;Suppl 7: 76-83.
34. Koscik R, Douglas J, Zaremba K, Lai H, Rock M, et al. Quality of life in children with cystic fibrosis [abstract]. Pediatric Pulmonology 2003;Suppl 25:358-359
35. Koscik R, Kosorok MR, Zaremba KM, Laxova A, Lai H, Douglas JA, et al. Early vitamin E deficiency and subsequent cognitive function: A potential benefit of neonatal screening for cystic fibrosis [abstract].. Pediatric Pulmonology 2003;Suppl 25:359.
36. Koscik RL, Douglas JA, Zaremba K, Rock MJ, Splaingard ML, Laxova A, et al. Quality of life of children with cystic fibrosis. Journal of Pediatrics 2005;147(3 Suppl 1):S64-8. (Pubitemid 41400261)
37. Koscik RL, Farrell PM, Kosorok MR, Zaremba KM, Laxova A, Lai HC, et al. Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics 2004;113(6):1549-1558 (Pubitemid 38697958)
38. Koscik RL, Shoff S, Lai H, Zaremba K, Laxova A, Rock M, et al. Is recovery of birth weight Z-score within 2 years of diagnosis related to quality of life in later childhood [abstract]. Pediatric Pulmonology 2006;41(Suppl 29):400.
39. Koscik RL, Zaremba K, Laxova A, Gershan W, Rock M, Farrell P. Quality of life in childhood and adolescence: do patients with CF and their parents agree? [abstract]. Pediatric Pulmonology 2006;41 (Suppl 29):399.
40. Kosorok MR, Farrell PM, Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Design and execution of the Wisconsin Cystic Fibrosis Newborn Screening trial [abstract]. Morbidity and Mortality Weekly Report 1997;46(No.):8.
41. Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatric Pulmonology 1998;26(2):81-88 (Pubitemid 28381468)
42. Lai HC, Chen ST, Koscik RE, Farrell PM, Kosorok MR. Occurrence of poor growth at diagnosis of Cystic Fibrosis [abstract]. Pediatric Pulmonology 1995;Suppl 12:311.
43. Lai HC, Kosorok MR, Laxova A, Davis LA, Fitz Simmon SC, Farrell PM. Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening.. Pediatrics 2000;105(1 Pt 1):53-61. (Pubitemid 30035718)
44. Lai HC, Kosorok MR, Laxova A, Farrell PM. Nutritional status of CF patients with meconium ileus (MI): a comparison with non-MI patients diagnosed early through neonatal screening [abstract]. Pediatric Pulmonology 1998;Suppl 17:356.
45. Lee DS, Rosenberg MA, Peterson A, Makholm L, Hoffman G, Laessig RH, et al. Analysis of costs of diagnosing cystic fibrosis with a newborn screening program. Journal of Paediatrics 2003;142(6):617-623 (Pubitemid 36737163)
46. Li Z, Kosorok MR, Farrell PM, Laxova A, West SHE, Green CG, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005;293(5):581-588 (Pubitemid 40171240)
47. Li Z, Lai HJ, Kosorok MR, Laxova A, Rock MJ, Splaingard ML, Farrell PM. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus. Pediatric Pulmonology 2004;38(4):277-284 (Pubitemid 39245108)
48. Marcus MS, Sondel SA, Farrell PM, Laxova A, Carey PM, Langhough R, et al. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. American Journal of Clinical Nutrition 1991;54(3):578-585 (Pubitemid 21898972)
49. Mischler E, Farrell P, Bruns T, Rock M, Tluczek A, Colby H, et al. Wisconsin experience with newborn screening for cystic fibrosis: no conclusions yet! [abstract]. Pediatric Pulmonology 1988;Suppl 2: 43-44
50. Mischler E, Farrell PM, Splaingard M, Laxova A, Koscik R. Pulmonary epidemiology over 10 years of cystic fibrosis in a screened population [abstract]. Pediatric Pulmonology 1995;Suppl 12:285.
51. Mischler E, Rock M, Farrell P, Bruns T, Palta M, Fost N, et al. Wisconsin experience with screening and clinical psychosocial description of patients with false positive screen [abstract]. Pediatric Pulmonology 1987;Suppl:81-83
52. Mischler EH, Marcus MS, MS, Sondel SA, Laxova A, Carey P, Langhough R, et al. Nutritional assessment of infants with cystic fibrosis diagnosed through screening. Pediatric Pulmonology 1991; Suppl 7:56-63.
53. Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, et al. Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counselling. Pediatrics 1998;102 (1 Pt 1):44-52. (Pubitemid 28309244)
54. Rock MJ, Davis L, Marcus M, Lai HC, Douglas J, Kosorok M, et al. Early nutritional intervention in infants with CF [abstract]. Pediatric Pulmonology 1999;Suppl 19:102-103
55. Rock MJ, Mischler EH, Farrell PM, Wei LJ, Bruns WT, Hassemer DJ, et al. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics 1990;85(6):1001-1007
56. Shoff S, Lai H. Recovery of birth weight Z-score within 2 years of diagnosis is positively associated with pulmonary status at age 6 years [abstract]. Pediatric Pulmonology 2006;41(Suppl 29):388.
57. Shoff SM, Ahn HY, Davis L, Lai HC, the Wisconsin CF Neonatal Screening Group. Temperal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis. Pediatrics 2006;117 (2):391-400. (Pubitemid 46071601)
58. Tluczek A, Mischler EH, Bowers B, Peterson NM, Morris ME, Farrell PM, et al. Psychological impact of false-positive results when screening for cystic fibrosis. Pediatric Pulmonology 1991;Suppl 7:29-37.
59. Tluczek A, Mischler EH, Farrell PM, Fost N, Peterson NM, Carey P, et al. Parents' knowledge of neonatal screening and response to false positive cystic fibrosis testing. Journal of Developmental and Behavioral Pediatrics 1992;13(3):181-186
60. Van Egmond AW, Kosorok MR, Koscik R, Laxova A, Farrell PM. Effect of linoleic acid intake on growth of infants with cystic fibrosis. American Journal of Clinical Nutrition 1996;63(5):746-752 (Pubitemid 26126595)
61. Wilfond BS, Farrell PM, Laxova A, Mischler E. Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Clinical Pediatrics 1994;33(1):2-7.
62. Barlocco EG, Benetazzo D, Borgo G, Braggion C, Canciani M, Caprini D, et al. Historical course of neonatal screening for cystic fibrosis (CF) in Veneto and surrounding areas. Evaluation over 12.8 years [abstract]. Proceedings of the Second International Conference on Neonatal Screening for Cystic Fibrosis; 1987. 1987:5-12.
63. Barlocco EG, Benetazzo D, Borgo G, Braggion C, Canciani M, Caprini D, et al. The study of factors affecting the causes of cystic fibrosis [abstract]. Proceedings of the Second International Conference on Neonatal Screening for Cystic Fibrosis; 1987. 1987:13-18
64. Barlocco EG, Mastella G, Borgo G, Braggion C, Cazzola G, Conforti M. Medical care and genetic factors in the outcome of the CF patients diagnosed by neonatal screening [abstract]. Proceedings of the Third International Conference on Neonatal Screening for Cystic Fibrosis; 1988. 1988:153-165
65. Mastella G, Barlocco EG, Antonacci B, Borgo G, Braggion C, Cazolla G, et al. Is neonatal screening advantageous? The answer of a wide 15 years follow-up study [abstract]. Proceedings of the Third International Conference on Neonatal Screening for Cystic Fibrosis; 1988. 1988:127-142
66. Mastella G, Castellani C, Faraguna D, Miano A, Zanolla L. Longterm outcome in patients with cystic fibrosis identified through newborn screening [abstract]. Pediatric Pulmonology 1995;Suppl 12:88-89
67. Carter E, Johnson S. A comparison of progress of children with cystic fibrosis diagnosed by immunoreactive trypsin screening or by clinical means [abstract]. Proceedings of the Second International Conference on Neonatal Screening for Cystic Fibrosis; 1987. 1987:65-66
68. Dauphinais RM. A cost analysis of blood-spot screening newborns for cystic fibrosis. Journal of Clinical Immunoassay 1992;15(2):121-125
69. Dauphinais RM. Comparative costs in diagnosing cystic fibrosis by blood-spot screening vs. non-screening [abstract]. Proceedings of the Fourth International Conference of Neonatal Screening for Cystic Fibrosis; 1990. 1990:12.
70. Dauphinais RM, Jezyk PD. IRT screening of newborns for cystic fibrosis: Connecticut experience [abstract]. Proceedings of the Third International Conference on Neonatal Screening for Cystic Fibrosis; 1988; Caen, France. 1988:230.
71. Lagoe 2005 {published data only} Lagoe E, Labella S, Arnold G, Rowley PT. Cystic fibrosis newborn screening: a pilot study tomaximize carrier screening. Genetic Testing 2005;9(3):255-260 (Pubitemid 41507758)
72. Additional references Armstrong 1997 Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, et al. Lower airway inflammation in infants and young children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 1997;156(4 Pt 1):1197-1204 (Pubitemid 27446528)
73. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatric Pulmonology 1995;20(2):63-70.
74. Baroni MA, Anderson YE, Mischler E. Cystic fibrosis newborn screening: Impact of early screening results on parenting stress. Pediatric Nursing 1997;23(2):143-151
75. Dankert-Roelse JE, teMeerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax 1995;50(7):712-718
76. Doull IJ, Ryley HC, Weller P, Goodchild MC. Cystic fibrosis-related deaths in infancy and the effect of newborn screening. Pediatric Pulmonology 2001;31(5):363-366
77. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: Current survival and population estimates to the year 2000. Thorax 1991;46(12):881-885
78. Farrell 1997 Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns T, et al. Nutritional benefits of neonatal screening for cystic fibrosis. New England Journal of Medicine 1997;337(14):963-969 (Pubitemid 27425952)
79. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics 2001;107(1):1-13.
80. Farrell 2003 Farrell PM, Li Z, Kosorok M, Laxova A, Green CG, Collins J, et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. American Journal of Respiratory and Critical Care Medicine 2003;168(9):1100-1108 (Pubitemid 37338940)
81. Fost N, Farrell PM. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Clinical Research 1989;37(3):495-500.
82. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. New England Journal of Medicine 1994;331:637-642
83. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560
84. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 1995;151(4): 1075-1082
85. Koscik R, Kosorok MR, Zaremba KM, Laxova A, Lai H, Douglas JA, et al. Early vitamin E deficiency and subsequent cognitive function: A potential benefit of neonatal screening for cystic fibrosis [abstract]. Pediatric Pulmonology 2003;Suppl 25:359.
86. Koscik 2004 Koscik RL, Farrell PM, Kosorok MR, Zaremba KM, Laxova A, Lai HC, et al. Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics 2004;113(6):1549-1558 (Pubitemid 38697958)
87. Koscik RL, Douglas JA, Zaremba K, Rock MJ, Splaingard ML, Laxova A, et al. Quality of life of children with cystic fibrosis. Journal of Pediatrics 2005;147(3 Suppl 1):S64-8.
88. Lee 2003 Lee DS, Rosenberg MA, Peterson A, Makholm L, Hoffman G, Laessig RH, et al. Analysis of costs of diagnosing cystic fibrosis with a newborn screening program. Journal of Pediatrics 2003;142(6):617-623 (Pubitemid 36737163)
89. Lewis PA. The epidemiology of cystic fibrosis. In: Hodson ME, Geddes DM editor(s). Cystic Fibrosis. London: Chapman & Hall Medical, 1995:1-5.
90. Li 2005 Li Z, Kosorok MR, Farrell PM, Laxova A, West SHE, Green CG, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005;293(5):581-588 (Pubitemid 40171240)
91. Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, et al. Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counselling. Pediatrics 1998;102 (1 Pt 1):44-52.
92. Pollitt RG. Screening for cystic fibrosis. Seminars in Neonatology 1998;3:9-15.
93. Schulz K, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273(5):408-412
94. Shoff SM, Ahn HY, Davis L, Lai HC, the Wisconsin CF Neonatal Screening Group. Temperal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis. Pediatrics 2006;117 (2):391-400.
95. Task Force 1983 Ad hoc task force on neonatal screening, Cystic Fbrosis Foundation. Neonatal screening for cystic fibrosis [position paper]. Pediatrics 1983;72(5):741-745 (Pubitemid 14232901)
96. Tluczek A, Mischler EH, Farrell PM, Fost N, Peterson NM, Carey P, et al. Parents' knowledge of neonatal screening and response to false positive cystic fibrosis testing. Journal of Developmental and Behavioral Pediatrics 1992;13(3):181-186
97. Wald 1998 Wald NJ, Morris JK. Neonatal screening for cystic fibrosis. No evidence yet of any benefit. BMJ 1998;316(7129):404-405 (Pubitemid 28121287)
98. Waters DL, Wilcken B, Irwig L, Van Esperen P, Mellis C, Simpson JM, et al. Clinical outcomes of newborn screening for cystic fibrosis. Archives of Disease in Childhood 1999;80(1):F1-F7.
99. Weller P. Personal communication 2007.
100. Wilcken 1993 Wilcken B. Newborn screening for cystic fibrosis: Its evolution and a review of the current situation. Screening 1993;2:43-62. (Pubitemid 23142886)